We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Handheld Device Uses Fiber Optic Sensor to Determine Correct Nasogastric Feeding Tube Placement

By HospiMedica International staff writers
Posted on 17 Jul 2023

Annually, nurses are tasked with inserting over a million feeding tubes into patients' stomachs for the delivery of nutrition, hydration, and medication. More...

It is reported that inaccurate placement of nasogastric tubes (NGTs) occurs in 1-3% of all insertions, which can lead to severe consequences including treatment delays and, in some cases, death. The majority of NGTs are inserted 'blind', as the procedure does not involve any form of visualization to confirm correct positioning before use. Traditional methods, in use for the past 20 years, are inherently flawed. The first technique to confirm NGT placement involves pH testing of the NGT aspirate. If a pH level of 5.5 or lower is achieved, the NGT is deemed safe, otherwise, chest X-rays are required. However, pH strips can fail in up to 45% of cases due to difficulty in obtaining aspirate, necessitating an X-ray for the patient and causing an average treatment delay of approximately eight hours. Now, a new electronic device specifically designed for correct NGT placement could eliminate the problem of incorrectly inserted feeding tubes.

NGPod Global (Cheshire, UK) has developed the NGPOD system, a device designed to tackle the risks associated with traditional nasogastric placement confirmation techniques. The portable NGPod device employs a fiber optic sensor that is introduced directly into the stomach via the feeding tube, eliminating the need for aspirate while transmitting light signals back to a handheld device. The NGPOD system also eliminates the need to aspirate gastric contents from the patient and reduces the risk of clinical interpretation errors by providing a safe bedside test that delivers a clear 'yes' or 'no' result. Furthermore, the device lowers the requirement for unnecessary X-rays to confirm placement, contributing to patient safety and cost-efficiency.

Using the product is straightforward and would require a maximum of 20 minutes for a professional to learn how to use the device with barriers set up in the device to prevent human errors. In a recent clinical trial consisting of 154 adult patients, researchers compared the performance of NGPod against the current pH strip procedures and found that it reduces the need for patients to use an X-ray by 61% while improving safety and human error. The device is currently in 12 hospitals in the UK with another eight scheduled to be implemented in the next six months.

Related Links:
NGPod Global 


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Bipolar Coagulation Generator
Aesculap
New
Hospital Data Analytics App
Alarm History Analytics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.